305 Participants Needed

Active Learning Strategy for Promoting Physical Activity in Children

TJ
Overseen ByTimothy J Walker, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center, Houston
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this study is to develop an implementation strategy to improve the use and sustainment of active learning in elementary schools and to conduct a feasibility study to evaluate the impact of the developed implementation strategy on the implementation and effectiveness of active learning.

Research Team

TJ

Timothy J Walker, PhD

Principal Investigator

The University of Texas Health Science Center, Houston

Eligibility Criteria

This trial is for lead teachers and children from kindergarten to fifth grade who can speak English or Spanish. It aims to help schools better use active learning to get kids moving more.

Inclusion Criteria

Lead teachers that teach kindergarten to fifth grade
My child is in kindergarten through fifth grade.

Exclusion Criteria

Non-English or Spanish speaking

Treatment Details

Interventions

  • implementation strategy for active learning to promote physical activity
  • Usual Implementation support
Trial OverviewThe study is testing a new way of getting schools to adopt active learning, which gets kids physically active while they learn. Some schools will receive the usual support; others will try this new strategy.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: implementation strategy for active learning to promote physical activityExperimental Treatment1 Intervention
Group II: Usual Implementation supportActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, Houston

Lead Sponsor

Trials
974
Recruited
361,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+